These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11128648)

  • 1. Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Dusonchet L; Meli M; Raimondi MV; D'Alessandro N; Tolomeo M
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2669-73. PubMed ID: 11128648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
    J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids, apoptosis and cancer.
    Simoni D; Tolomeo M
    Curr Pharm Des; 2001 Nov; 7(17):1823-37. PubMed ID: 11562311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
    Roberti M; Pizzirani D; Simoni D; Rondanin R; Baruchello R; Bonora C; Buscemi F; Grimaudo S; Tolomeo M
    J Med Chem; 2003 Jul; 46(16):3546-54. PubMed ID: 12877593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.
    Simoni D; Invidiata FP; Rondanin R; Grimaudo S; Cannizzo G; Barbusca E; Porretto F; D'Alessandro N; Tolomeo M
    J Med Chem; 1999 Dec; 42(24):4961-9. PubMed ID: 10585206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines.
    Tolomeo M; Grimaudo S; Milano S; La Rosa M; Ferlazzo V; Di Bella G; Barbera C; Simoni D; D'Agostino P; Cillari E
    Br J Pharmacol; 2001 May; 133(2):306-14. PubMed ID: 11350867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells.
    Tolomeo M; Grimaudo S; Di Cristina A; Roberti M; Pizzirani D; Meli M; Dusonchet L; Gebbia N; Abbadessa V; Crosta L; Barucchello R; Grisolia G; Invidiata F; Simoni D
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1709-26. PubMed ID: 15878840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Tarasiuk J
    Eur J Pharmacol; 2013 Dec; 721(1-3):141-50. PubMed ID: 24076328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
    Greene LM; Nathwani SM; Bright SA; Fayne D; Croke A; Gagliardi M; McElligott AM; O'Connor L; Carr M; Keely NO; O'Boyle NM; Carroll P; Sarkadi B; Conneally E; Lloyd DG; Lawler M; Meegan MJ; Zisterer DM
    J Pharmacol Exp Ther; 2010 Nov; 335(2):302-13. PubMed ID: 20699436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
    Roberti M; Pizzirani D; Recanatini M; Simoni D; Grimaudo S; Di Cristina A; Abbadessa V; Gebbia N; Tolomeo M
    J Med Chem; 2006 May; 49(10):3012-8. PubMed ID: 16686543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
    Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
    J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Flow Cytometric Analysis of Stilbene-Dependent Apoptosis in Drug Resistant Human Leukemic Cell Lines.
    Czop M; Bogucka-Kocka A; Kubrak T; Knap-Czop K; Makuch-Kocka A; Galkowski D; Wawer J; Kocki T; Kocki J
    Molecules; 2019 May; 24(10):. PubMed ID: 31108853
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action.
    Garattini E; Gianni M; Terao M
    Curr Pharm Des; 2004; 10(4):433-48. PubMed ID: 14965204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    J Pharm Pharmacol; 2013 Jun; 65(6):855-67. PubMed ID: 23647679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidin-1, a peanut stilbenoid, induces programmed cell death in human leukemia HL-60 cells.
    Huang CP; Au LC; Chiou RY; Chung PC; Chen SY; Tang WC; Chang CL; Fang WH; Lin SB
    J Agric Food Chem; 2010 Dec; 58(23):12123-9. PubMed ID: 21067217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic effects of thiazolobenzimidazole derivatives on sensitive and multidrug resistant leukaemic cells.
    Grimaudo S; Raimondi MV; Capone F; Chimirri A; Poretto F; Monforte AM; Simoni D; Tolomeo M
    Eur J Cancer; 2001 Jan; 37(1):122-30. PubMed ID: 11165139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new chalone adamantyl arotinoids having RXRα-modulating and anticancer activities.
    Ao M; Hu X; Qian Y; Li B; Zhang J; Cao Y; Zhang Y; Guo K; Qiu Y; Jiang F; Wu Z; Fang M
    Bioorg Chem; 2021 Aug; 113():104961. PubMed ID: 34023650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.
    Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.